Related references
Note: Only part of the references are listed.The 2020 WHO Classification What's New in Soft Tissue Tumor Pathology?
Michael E. Kallen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
Livnat Jerby-Arnon et al.
NATURE MEDICINE (2021)
Germline genetic contribution to the immune landscape of cancer
Rosalyn W. Sayaman et al.
IMMUNITY (2021)
Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
Rosanna L. Wustrack et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
Angelika M. Starzer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas
Lucie Darmusey et al.
CANCERS (2021)
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis
Michael Saerens et al.
EUROPEAN JOURNAL OF CANCER (2021)
Molecular determinants of response to PD-L1 blockade across tumor types
Romain Banchereau et al.
NATURE COMMUNICATIONS (2021)
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction
Jinxiu Li et al.
CANCER DISCOVERY (2021)
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
Marta Sbaraglia et al.
PATHOLOGICA (2021)
The current landscape of rhabdomyosarcomas: an update
Julia Leiner et al.
VIRCHOWS ARCHIV (2020)
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Emily Z. Keung et al.
CLINICAL CANCER RESEARCH (2020)
Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
Kim Bich Nguyen et al.
JOURNAL OF CELL BIOLOGY (2020)
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez et al.
NATURE (2020)
Epigenetic Therapy for Epithelioid Sarcoma
Scott B. Rothbart et al.
CELL (2020)
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
Lingling Chen et al.
CLINICAL CANCER RESEARCH (2020)
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
Jordan L. Kohlmeyer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation
Valentina Indio et al.
FRONTIERS IN IMMUNOLOGY (2020)
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli et al.
FRONTIERS IN ONCOLOGY (2020)
Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
Annalisa Astolfi et al.
FRONTIERS IN ONCOLOGY (2020)
Cell Cycle Regulation Meets Tumor Immunosuppression
Jinyang Li et al.
TRENDS IN IMMUNOLOGY (2020)
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
Jason Yongsheng Chan et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
Chuan Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
Yarne Klaver et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
Maud Toulmonde et al.
EBIOMEDICINE (2020)
Tumor-associated tertiary lymphoid structure predicts postoperative outcomes in patients with primary gastrointestinal stromal tumors
Qiaowei Lin et al.
ONCOIMMUNOLOGY (2020)
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas
Amanda R. Dancsok et al.
ONCOIMMUNOLOGY (2020)
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Gerardo A. Vitiello et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Breelyn A. Wilky et al.
LANCET ONCOLOGY (2019)
CD163+immune cell infiltrates and presence of CD54+microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
Jakob Nikolas Kather et al.
SCIENTIFIC REPORTS (2019)
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
Jason J. Luke et al.
CLINICAL CANCER RESEARCH (2019)
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
Alessandra Tuccitto et al.
VIRCHOWS ARCHIV (2019)
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment
Mark A. J. Gorris et al.
JOURNAL OF IMMUNOLOGY (2018)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives
Brigitte C. Widemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours
Armelle Dufresne et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Koichi Ogura et al.
NATURE COMMUNICATIONS (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas A Phase 2 Clinical Trial
Maud Toulmonde et al.
JAMA ONCOLOGY (2018)
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy
Sangeeta Goswami et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy
Marvin Kuske et al.
PHARMACOLOGICAL RESEARCH (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George et al.
IMMUNITY (2017)
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
Marcella Tazzari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Imatinib in Dermatofibrosarcoma: Targeted Therapy or Immunotherapy?
Selma Ugurel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Epigenetics and immunotherapy: The current state of play
Jennifer Dunn et al.
MOLECULAR IMMUNOLOGY (2017)
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
Takahiro Tsujikawa et al.
CELL REPORTS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Silvia Stacchiotti et al.
CLINICAL CANCER RESEARCH (2016)
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST
Monica Brenca et al.
JOURNAL OF PATHOLOGY (2016)
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
Alessandro De Vita et al.
ONCOTARGETS AND THERAPY (2016)
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
Marcella Tazzari et al.
BMC CANCER (2015)
New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype
Jamie Lim et al.
CLINICAL CANCER RESEARCH (2015)
Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies
Chiara Castelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
M. Tazzari et al.
BRITISH JOURNAL OF CANCER (2014)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Vinod P. Balachandran et al.
NATURE MEDICINE (2011)
Share Paper
